Trials / Completed
CompletedNCT03424863
Blood Pressure Changes During Moderate Intensity Strength Training in Aortic Stent-graft Patients
Peak Systolic Blood Pressure in Heart Patients With Aortic Stent-graft During Moderate Intensity Strength Training: A Descriptive Intervention Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Marius Henriksen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Patients with an aortic stent graft are recommended to do muscle strengthening exercise as part of their rehabilitation. But, as excess blood pressure pose a risk to the integrity of the stent graft, high intensity muscle strengthening exercise may potentially be detrimental, and hence moderate intensity muscle strengthening is recommended. However, the blood pressure changes during moderate intensity strengthening exercises are unknown, and this study aims to quantify these among patients and compare them to those of healthy volunteers. Purpose: The purpose of this study is to investigate the increase in blood pressure during quadriceps muscle strength training in patients with aortic stent graft. Methods: Patients with aortic stent graft will be included. The participants are investigated once. During the investigation, the blood pressure increase during a single strength training exercise (leg press) is measured. The strength training exercise is done at 60% of maximal strength (moderate intensity) corresponding to 15 Repitition Maximum (RM) (a load that can be lifted exactly 15 times).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Moderate Intensity Muscle Strengthening | 1 session of lower extremity muscle strengthening at moderate intensity (60% of estimated maximal muscle strength). The exercise is performed on one single day. |
Timeline
- Start date
- 2018-02-22
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
- First posted
- 2018-02-07
- Last updated
- 2018-12-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03424863. Inclusion in this directory is not an endorsement.